Developer docs
API playgroundTry for free, no card

Search company profiles

Atinary

Full company profile

uuid0000u79

Namestring
Atinary
Legal namestring
Atinary Technologies, Inc.
Websiteurl
atinary.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Atinary is a Swiss-American deeptech company founded in 2019 by Harvard PhDs Dr. Hermann Tribukait (CEO) and Dr. Loïc Roch (CTO), headquartered at the Biopôle life-sciences campus in Epalinges/Lausanne, Switzerland with a US corporate base in Menlo Park, Delaware, and a Self-Driving Lab in Boston's Kendall Square. The company has built the SDLabs AI Platform — a no-code, cloud-hosted agentic AI platform that integrates proprietary Bayesian Optimization algorithms, the SeMOpt transfer-learning module, and the Falcon multi-objective optimizer for solving complex chemistry, materials, and pharmaceutical R&D problems — and pairs it with physical Self-Driving Labs that integrate robotics from ABB, Agilent, Bruker, Chemspeed, and Mettler-Toledo into closed-loop Design-Make-Test-Analyze-Learn cycles capable of running 200–400 experiments per day.

The platform serves pharmaceutical, biotechnology, chemicals, materials, cosmetics, energy, and agri-food customers, with flagship enterprise relationships including Takeda (drug development), Snapdragon Chemistry / Cambrex (oligonucleotide synthesis), dsm-firmenich (hydroformylation catalyst optimization), IBM Research Europe (RoboRXN integration), Solaronix, and academic collaborations with ETH Zurich, MIT, Stanford, and DTU. The company has demonstrated validated outcomes including 5x–100x reductions in development time versus DOE/OFAT, a 1000x acceleration in CO2-to-methanol catalyst discovery with ETH, and 95–97% cost reductions in Rhodium catalyst loading for dsm-firmenich.

Atinary monetizes through annual SDLabs SaaS subscriptions complemented by multi-year Self-Driving Lab managed-service contracts delivered via direct enterprise field sales, with SOC-2 Type II, HIPAA, and GDPR compliance hosted on AWS. Total disclosed funding is approximately $7M equivalent ($5M seed led by AgFunder in September 2023 plus a CHF 2M Innosuisse grant in April 2023), supporting a 16-person team across 13 nationalities. Recognition includes the 2026 World Economic Forum Technology Pioneer designation, Forbes 30Under30 (2025), and the Solar Impulse Efficient Solution Label (2022).

Short descriptiontext

Atinary is a Swiss-American deeptech company founded in 2019 that builds the SDLabs no-code AI platform and physical Self-Driving Labs integrating Bayesian optimization with robotics, serving pharmaceutical, biotech, chemicals, and materials R&D teams through enterprise SaaS subscriptions and managed lab services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLausanne, Switzerland
HQ citystring
Lausanne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI R&D platform, self-driving labs, Bayesian optimization, autonomous experimentation, pharmaceutical R&D
Industry3 codes
PRIMARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAAABAF
Model Deployment, Serving & Inference Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management
NAICS code4 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services5415
  • Computer Systems Design Services541512
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Commercial Physical & Biological Research8731
Product category
AI-driven R&D platform for chemistry, materials, and pharmaceutical discovery
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Annual subscription model for access to SDLabs AI platform and Self-Driving Labs technology. Includes onboarding, support, and enterprise-grade security (SOC-2, HIPAA, GDPR compliance).

atinary.com
2Self-Driving Lab Services
TypeManaged Services
Description

Fully integrated production-grade Self-Driving Lab platform combining AI, robotics, automation, and precision instrumentation. Delivered as a service with full integration into customer workflows.

atinary.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Enterprise subscription with full platform access
ModelSubscriptionBilling cadenceAnnual
Notes

Annual subscription model. Onboard in under two hours. SOC-2, HIPAA, and GDPR compliant. State-of-the-art data, privacy, and IP protection.

atinary.com
2Self-Driving Lab deployment
ModelHybridBilling cadenceMulti-year contract
Notes

Fully integrated production-grade platform combining AI, robotics, and precision instrumentation. Delivered as a service.

atinary.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1SDLabs
Description

Atinary's no-code AI platform for accelerated optimization and discovery of molecules and materials

atinary.com
+3 more records
Core offering1 text field

Atinary develops and sells the SDLabs AI Platform, a cloud-based no-code software that combines Bayesian optimization machine learning, transfer-learning algorithms (SeMOpt, Falcon), data analytics, and visualization to solve multi-objective optimization problems in chemistry, materials, and pharmaceutical R&D. The company also delivers Self-Driving Labs, a fully integrated autonomous laboratory system combining AI, robotics (ABB, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise to execute closed-loop Design-Make-Test-Analyze-Learn cycles. Customers access the platform via enterprise annual subscriptions, with deployment in under two hours.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 5x to 100x reduction in development time and costs compared to DOE and OFAT
+8 more records
Product overview1 text field

Atinary offers a unified AI-driven R&D platform centered on the SDLabs AI Platform and Self-Driving Labs technology. The SDLabs platform provides a code-free interface for Bayesian Optimization and multi-objective optimization, while the Self-Driving Labs deliver fully integrated autonomous laboratory capabilities. Key components include the SeMOpt transfer-learning algorithm for knowledge reuse across experiments and the Falcon optimizer for specific discovery applications. The platform serves pharma, biotech, chemicals, cosmetics, and energy industries with solutions for formulation, catalysis, and synthesis optimization.

Product and service4 records
1SDLabs AI Platform
CategoryAI-driven R&D software platform
Description

Cloud-based, code-free, agentic AI platform integrating machine learning optimizers, data analytics, and visualization into a single intuitive interface. Enables scientists without programming or AI expertise to solve complex multi-objective optimization challenges in chemistry, materials, and pharmaceutical R&D. Deploys in under two hours and integrates with existing workflows, LIMS, ELN, and optional robotic hardware.

2Self-Driving Labs
CategoryAutonomous laboratory systems and services
Description

Fully integrated autonomous laboratory technology that combines AI, robotics (ABB GoFa cobots, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise into a unified closed-loop ecosystem. Executes Design-Make-Test-Analyze-Learn (DMTA-L) cycles continuously, with outcomes automatically feeding back into ML algorithms to determine next experiments. Runs 200-400 experiments per day.

3SeMOpt Algorithm
CategoryOptimization algorithm / software module
Description

Semantic Memory Enhanced Optimization (SeMOpt) transfer-learning algorithm that accelerates optimization processes by leveraging existing knowledge from past experiments and databases. Automatically identifies key information and guides optimization algorithms to the most promising parameter region from the start, working with any general-purpose Bayesian optimization algorithm.

4Falcon Optimizer
CategoryOptimization algorithm / software module
Description

Atinary's proprietary machine learning optimizer used for multi-objective optimization, including perovskite solar cell active layer composition and hydroformylation catalysis. Explores multi-dimensional parameter spaces and suggests experimental conditions through iterative optimization campaigns.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
1ABB Robotics
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

ABB Robotics provides GoFa cobots and lab automation technology for Atinary's Self-Driving Labs in Boston. Demonstrated multi-vendor interoperability with instruments from Agilent and Mettler Toledo at SLAS 2026. ABB hosts roundtable on AI and robotics integration in lab operations.

atinary.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

Agilent provides laboratory instrumentation integrated into Atinary's Scientific Discovery Factories in Boston. Multi-vendor workflows demonstrated at SLAS 2026 alongside ABB robotics.

3Mettler-Toledo
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

Mettler-Toledo provides analytical instruments for Atinary's automated lab workflows. Demonstrated in multi-vendor interoperability workflows at SLAS 2026 with ABB robotics.

atinary.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

Chemspeed provides automated synthesis platforms integrated into Atinary's Self-Driving Labs. Longstanding collaboration including joint Demo Lab opening in Basel and published research on automated experimentation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

Bruker provides analytical instrumentation for Atinary's Self-Driving Lab in Boston, part of the integrated autonomous platform for small-molecule synthesis and catalysis.

Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

Innovation advisor organization supporting Atinary's participation in Swiss BioTools community and Lausanne ecosystem development.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-02-01
Description

Collaboration with Prof. Rogelio Hernández-López at Stanford to advance T cell engineering using SDLabs for synthetic circuit optimization in CAR-T cell therapy development.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

Strategic collaboration integrating Atinary's SDLabs platform with Snapdragon's LabOSTM software for fully-automated AI-driven Solid-Phase Oligonucleotide Synthesizer. Demonstrated 18% yield increase and 22% cost reduction.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2024-07-01
Description

AI-informatics partnership to deliver integrated AI technology for planning, design, and analysis of high throughput and parallel chemistry experiments. First project focused on smart HTE; foundation for smart, automated labs of the future.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

3-year collaboration with Pioneer Center for Accelerating P2X Materials Discovery at Technical University of Denmark. SDLabs platform to accelerate sustainable materials discovery for Power-to-X applications.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

Strategic collaboration with Takeda, the largest Japanese pharmaceutical company. Takeda leverages Atinary's AI Self-Driving Labs technology for drug development. Expanded to include Atinary Lab in Boston for demonstration and co-development.

12AWS
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Atinary joined AWS Partner Network. AWS provides cloud infrastructure for secure, scalable hosting of SDLabs platform and data analytics. Enterprise-grade reliability for customer deployments.

atinary.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

MIT's Buonassisi Lab used SDLabs for perovskite solar cell optimization. Completed 4-week project in 33 experiments that would have taken 2+ years with traditional methods. Prof. Buonassisi called it 'the iPhone of R&D'.

14ViperLab
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Collaboration for perovskite solar cell optimization using SDLabs. Automated search for optimal perovskite layer properties, identifying optimal conditions after 80 samples in 5 iterations.

atinary.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-05-01
Description

MIT Laboratory for Soft Materials uses Atinary's SDLabs platform to optimize self-assembly in block copolymer thin films for nano-lithography and microelectronics applications.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-03-01
Description

Collaboration using Atinary's Falcon ML algorithm and SDLabs platform for hydroformylation R&D optimization. Achieved 10-30x reduction in Rhodium catalyst loading and 95-97% cost reduction. Published in ACS Catalysis 2025.

17JAG Group
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-07-01
Description

Strategic partnership offering turnkey solution combining Atinary's AI/ML technology with JAG's robotics and automation expertise. Targets pharma, biotech, and clean energy sectors. Strengthens Swiss innovation ecosystem.

atinary.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-07-01
Description

Collaboration with Swiss national catalysis initiative SwissCAT+ at ETH Zurich. Demonstrated 1000x acceleration in CO2 to methanol catalyst discovery. Joint publication featured on cover of Chem Catalysis. Dr. Paco Laveille leads ETH Catalysis Hub.

Strategic tierCoreTypeOthersAnnounced on2022-02-01
Description

Biopôle startup fund recipient. Atinary's Swiss office located at Biopôle life sciences campus in Lausanne. Part of Europe's leading life-science hub ecosystem.

Strategic tierMinorTypeOthersAnnounced on2022-01-01
Description

SDLabs platform received Solar Impulse Efficient Solution Label for sustainable solutions demonstrating environmental and economic performance.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2021-11-01
Description

Collaboration integrating Atinary's SDLabs platform with IBM's RoboRXN for autonomous chemical reaction optimization. Combines ML and automation for data-driven chemistry. Published results demonstrating 80%+ yield in just 23 experiments.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI platform for materials and chemicals R&D that ingests experimental data and optimizes formulations and processes. Directly comparable to Atinary's SDLabs platform in target market (specialty chemicals, advanced materials) and value proposition (faster, cheaper experimentation via ML).

TypeBroad incumbent
Description

Public, multi-product computational chemistry and materials science platform serving pharma and industrial R&D. Overlaps with Atinary on AI-driven molecular and materials optimization, but Schrödinger is a broad platform with physics-based simulation plus ML, while Atinary focuses on closed-loop autonomous experimentation.

TypeDirect peer
Description

IBM's autonomous chemistry platform combining NLP-driven synthesis planning with robotic execution. Direct technical overlap with Atinary's Self-Driving Labs, and IBM is already an active collaborator (chemical reaction optimization published 80%+ yield in 23 experiments), making it both a partner and a potential competitor.

TypeDirect peer
Description

Digital chemistry company building autonomous chemical synthesis platforms using AI-driven code-to-compound workflows. Closely aligned with Atinary's Self-Driving Labs vision in autonomous chemistry execution and serves overlapping pharma/chemicals customers.

TypeDirect peer
Description

Remote, fully-automated laboratory platform allowing scientists to run experiments via software interfaces. Competes with Atinary in the lab-automation-as-a-service category, though Emerald focuses on broad wet-lab outsourcing while Atinary emphasizes AI-driven autonomous optimization.

TypeDirect peer
Description

AI and robotics platform for materials discovery targeting chemicals, energy, and consumer products. Directly comparable to Atinary's value proposition of combining ML with automated experimentation to accelerate materials R&D.

TypeEmerging player
Description

AI platform for small molecule drug design focused on generative chemistry and multi-parameter optimization. Comparable in pharmaceutical AI optimization, but Iktos focuses on molecule generation rather than closed-loop lab execution.

TypeDirect peer
Description

Robotics-as-a-service platform for drug discovery combining automated experimentation with ML-driven analysis. Directly comparable to Atinary's Self-Driving Labs in pharma/biotech R&D automation.

TypeBroad incumbent
Description

AI-driven drug discovery platform combining data, computation, and lab automation across the full preclinical pipeline. Overlaps with Atinary in AI for pharma R&D, though Valo is a vertically integrated drug developer rather than a platform vendor.

TypeRegional player
Description

AI foundation-model platform for biological R&D with strong presence in Asia. Comparable to Atinary in applying large AI models to scientific discovery, though focused on biologics rather than chemistry/materials and concentrated outside of Atinary's core US/European markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Atinary

AI-driven R&D platform for chemistry, materials, and pharmaceutical discoveryatinary.com

Atinary is a Swiss-American deeptech company founded in 2019 that builds the SDLabs no-code AI platform and physical Self-Driving Labs integrating Bayesian optimization with robotics, serving pharmaceutical, biotech, chemicals, and materials R&D teams through enterprise SaaS subscriptions and managed lab services.

What Atinary does

Atinary is a Swiss-American deeptech company founded in 2019 by Harvard PhDs Dr. Hermann Tribukait (CEO) and Dr. Loïc Roch (CTO), headquartered at the Biopôle life-sciences campus in Epalinges/Lausanne, Switzerland with a US corporate base in Menlo Park, Delaware, and a Self-Driving Lab in Boston's Kendall Square. The company has built the SDLabs AI Platform — a no-code, cloud-hosted agentic AI platform that integrates proprietary Bayesian Optimization algorithms, the SeMOpt transfer-learning module, and the Falcon multi-objective optimizer for solving complex chemistry, materials, and pharmaceutical R&D problems — and pairs it with physical Self-Driving Labs that integrate robotics from ABB, Agilent, Bruker, Chemspeed, and Mettler-Toledo into closed-loop Design-Make-Test-Analyze-Learn cycles capable of running 200–400 experiments per day.

The platform serves pharmaceutical, biotechnology, chemicals, materials, cosmetics, energy, and agri-food customers, with flagship enterprise relationships including Takeda (drug development), Snapdragon Chemistry / Cambrex (oligonucleotide synthesis), dsm-firmenich (hydroformylation catalyst optimization), IBM Research Europe (RoboRXN integration), Solaronix, and academic collaborations with ETH Zurich, MIT, Stanford, and DTU. The company has demonstrated validated outcomes including 5x–100x reductions in development time versus DOE/OFAT, a 1000x acceleration in CO2-to-methanol catalyst discovery with ETH, and 95–97% cost reductions in Rhodium catalyst loading for dsm-firmenich.

Atinary monetizes through annual SDLabs SaaS subscriptions complemented by multi-year Self-Driving Lab managed-service contracts delivered via direct enterprise field sales, with SOC-2 Type II, HIPAA, and GDPR compliance hosted on AWS. Total disclosed funding is approximately $7M equivalent ($5M seed led by AgFunder in September 2023 plus a CHF 2M Innosuisse grant in April 2023), supporting a 16-person team across 13 nationalities. Recognition includes the 2026 World Economic Forum Technology Pioneer designation, Forbes 30Under30 (2025), and the Solar Impulse Efficient Solution Label (2022).

Atinary firmographics

Firmographics
Name
Atinary
Legal name
Atinary Technologies, Inc.
Website
https://atinary.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Atinary is a Swiss-American deeptech company founded in 2019 that builds the SDLabs no-code AI platform and physical Self-Driving Labs integrating Bayesian optimization with robotics, serving pharmaceutical, biotech, chemicals, and materials R&D teams through enterprise SaaS subscriptions and managed lab services.
Ownership category
akta.pro rank

Atinary industry classification

Industry
Product category
AI-driven R&D platform for chemistry, materials, and pharmaceutical discovery
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (5415), Computer Systems Design Services (541512), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAAABAF
Model Deployment, Serving & Inference Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management

Keywords

  • AI R&D platform
  • Self-driving labs
  • Bayesian optimization
  • Autonomous experimentation
  • Pharmaceutical R&D

Where Atinary is headquartered

Location

Headquarters

HQ city
Lausanne
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Atinary business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription: Annual subscription model for access to SDLabs AI platform and Self-Driving Labs technology. Includes onboarding, support, and enterprise-grade security (SOC-2, HIPAA, GDPR compliance).
  2. Self-Driving Lab Services: Fully integrated production-grade Self-Driving Lab platform combining AI, robotics, automation, and precision instrumentation. Delivered as a service with full integration into customer workflows.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription with full platform access
HybridMulti-year contractSelf-Driving Lab deployment

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Atinary product offering

Product offering

Core offering

Atinary develops and sells the SDLabs AI Platform, a cloud-based no-code software that combines Bayesian optimization machine learning, transfer-learning algorithms (SeMOpt, Falcon), data analytics, and visualization to solve multi-objective optimization problems in chemistry, materials, and pharmaceutical R&D. The company also delivers Self-Driving Labs, a fully integrated autonomous laboratory system combining AI, robotics (ABB, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise to execute closed-loop Design-Make-Test-Analyze-Learn cycles. Customers access the platform via enterprise annual subscriptions, with deployment in under two hours.

Product overview

Atinary offers a unified AI-driven R&D platform centered on the SDLabs AI Platform and Self-Driving Labs technology. The SDLabs platform provides a code-free interface for Bayesian Optimization and multi-objective optimization, while the Self-Driving Labs deliver fully integrated autonomous laboratory capabilities. Key components include the SeMOpt transfer-learning algorithm for knowledge reuse across experiments and the Falcon optimizer for specific discovery applications. The platform serves pharma, biotech, chemicals, cosmetics, and energy industries with solutions for formulation, catalysis, and synthesis optimization.

Differentiator

Problem solved

Functional benefit

Brands

  • SDLabs: Atinary's no-code AI platform for accelerated optimization and discovery of molecules and materials
  • Self-Driving Labs
  • SeMOpt
  • Nexus

Products and services

  • SDLabs AI Platform Cloud-based, code-free, agentic AI platform integrating machine learning optimizers, data analytics, and visualization into a single intuitive interface. Enables scientists without programming or AI expertise to solve complex multi-objective optimization challenges in chemistry, materials, and pharmaceutical R&D. Deploys in under two hours and integrates with existing workflows, LIMS, ELN, and optional robotic hardware.
  • Self-Driving Labs Fully integrated autonomous laboratory technology that combines AI, robotics (ABB GoFa cobots, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise into a unified closed-loop ecosystem. Executes Design-Make-Test-Analyze-Learn (DMTA-L) cycles continuously, with outcomes automatically feeding back into ML algorithms to determine next experiments. Runs 200-400 experiments per day.
  • SeMOpt Algorithm Semantic Memory Enhanced Optimization (SeMOpt) transfer-learning algorithm that accelerates optimization processes by leveraging existing knowledge from past experiments and databases. Automatically identifies key information and guides optimization algorithms to the most promising parameter region from the start, working with any general-purpose Bayesian optimization algorithm.
  • Falcon Optimizer Atinary's proprietary machine learning optimizer used for multi-objective optimization, including perovskite solar cell active layer composition and hydroformylation catalysis. Explores multi-dimensional parameter spaces and suggests experimental conditions through iterative optimization campaigns.

Quantifiable outcome

  • 5x to 100x reduction in development time and costs compared to DOE and OFAT
  • +8 more outcomes

Companies that use Atinary

Customer profile

Named customers11 records

Segments6 records

Ideal customer profiles4 records

Atinary technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability6 records

Feature5 records

Atinary partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered core, minor, strategic and flagship.

  • ABB RoboticscoreTechnology or Integration · 1 February 2026ABB Robotics provides GoFa cobots and lab automation technology for Atinary's Self-Driving Labs in Boston. Demonstrated multi-vendor interoperability with instruments from Agilent and Mettler Toledo at SLAS 2026. ABB hosts roundtable on AI and robotics integration in lab operations.
  • AgilentcoreTechnology or Integration · 1 February 2026Agilent provides laboratory instrumentation integrated into Atinary's Scientific Discovery Factories in Boston. Multi-vendor workflows demonstrated at SLAS 2026 alongside ABB robotics.
  • Mettler-ToledocoreTechnology or Integration · 1 February 2026Mettler-Toledo provides analytical instruments for Atinary's automated lab workflows. Demonstrated in multi-vendor interoperability workflows at SLAS 2026 with ABB robotics.
  • ChemspeedcoreTechnology or Integration · 1 February 2026Chemspeed provides automated synthesis platforms integrated into Atinary's Self-Driving Labs. Longstanding collaboration including joint Demo Lab opening in Basel and published research on automated experimentation.
  • BrukercoreTechnology or Integration · 1 February 2026Bruker provides analytical instrumentation for Atinary's Self-Driving Lab in Boston, part of the integrated autonomous platform for small-molecule synthesis and catalysis.
  • InnovaudminorOthers · 1 January 2026Innovation advisor organization supporting Atinary's participation in Swiss BioTools community and Lausanne ecosystem development.
  • Stanford University (Hernández-López Lab)strategicStrategic or Co-development Partner · 1 February 2025Collaboration with Prof. Rogelio Hernández-López at Stanford to advance T cell engineering using SDLabs for synthetic circuit optimization in CAR-T cell therapy development.
  • Snapdragon Chemistry (Cambrex)strategicStrategic or Co-development Partner · 1 September 2024Strategic collaboration integrating Atinary's SDLabs platform with Snapdragon's LabOSTM software for fully-automated AI-driven Solid-Phase Oligonucleotide Synthesizer. Demonstrated 18% yield increase and 22% cost reduction.
  • ACD/LabsstrategicTechnology or Integration · 1 July 2024AI-informatics partnership to deliver integrated AI technology for planning, design, and analysis of high throughput and parallel chemistry experiments. First project focused on smart HTE; foundation for smart, automated labs of the future.
  • DTU / CAPeXstrategicStrategic or Co-development Partner · 1 April 20243-year collaboration with Pioneer Center for Accelerating P2X Materials Discovery at Technical University of Denmark. SDLabs platform to accelerate sustainable materials discovery for Power-to-X applications.
  • TakedaflagshipStrategic or Co-development Partner · 1 February 2024Strategic collaboration with Takeda, the largest Japanese pharmaceutical company. Takeda leverages Atinary's AI Self-Driving Labs technology for drug development. Expanded to include Atinary Lab in Boston for demonstration and co-development.
  • AWScoreTechnology or Integration · 1 January 2024Atinary joined AWS Partner Network. AWS provides cloud infrastructure for secure, scalable hosting of SDLabs platform and data analytics. Enterprise-grade reliability for customer deployments.
  • MIT (Buonassisi Lab)strategicStrategic or Co-development Partner · 1 January 2024MIT's Buonassisi Lab used SDLabs for perovskite solar cell optimization. Completed 4-week project in 33 experiments that would have taken 2+ years with traditional methods. Prof. Buonassisi called it 'the iPhone of R&D'.
  • ViperLabminorStrategic or Co-development Partner · 1 January 2024Collaboration for perovskite solar cell optimization using SDLabs. Automated search for optimal perovskite layer properties, identifying optimal conditions after 80 samples in 5 iterations.
  • MIT (Alexander-Katz Lab)strategicStrategic or Co-development Partner · 1 May 2023MIT Laboratory for Soft Materials uses Atinary's SDLabs platform to optimize self-assembly in block copolymer thin films for nano-lithography and microelectronics applications.
  • dsm-firmenichstrategicStrategic or Co-development Partner · 1 March 2023Collaboration using Atinary's Falcon ML algorithm and SDLabs platform for hydroformylation R&D optimization. Achieved 10-30x reduction in Rhodium catalyst loading and 95-97% cost reduction. Published in ACS Catalysis 2025.
  • JAG GroupstrategicStrategic or Co-development Partner · 1 July 2022Strategic partnership offering turnkey solution combining Atinary's AI/ML technology with JAG's robotics and automation expertise. Targets pharma, biotech, and clean energy sectors. Strengthens Swiss innovation ecosystem.
  • ETH Zurich (SwissCAT+)strategicStrategic or Co-development Partner · 1 July 2022Collaboration with Swiss national catalysis initiative SwissCAT+ at ETH Zurich. Demonstrated 1000x acceleration in CO2 to methanol catalyst discovery. Joint publication featured on cover of Chem Catalysis. Dr. Paco Laveille leads ETH Catalysis Hub.
  • BiopôlecoreOthers · 1 February 2022Biopôle startup fund recipient. Atinary's Swiss office located at Biopôle life sciences campus in Lausanne. Part of Europe's leading life-science hub ecosystem.
  • Solar Impulse FoundationminorOthers · 1 January 2022SDLabs platform received Solar Impulse Efficient Solution Label for sustainable solutions demonstrating environmental and economic performance.
  • IBM Research EuropestrategicStrategic or Co-development Partner · 1 November 2021Collaboration integrating Atinary's SDLabs platform with IBM's RoboRXN for autonomous chemical reaction optimization. Combines ML and automation for data-driven chemistry. Published results demonstrating 80%+ yield in just 23 experiments.

Scale indicators6 records

Recent moves9 records

Expansion highlights7 records

Atinary competitors and assessment

Company assessment

Direct peers

  • Citrine Informatics: AI platform for materials and chemicals R&D that ingests experimental data and optimizes formulations and processes. Directly comparable to Atinary's SDLabs platform in target market (specialty chemicals, advanced materials) and value proposition (faster, cheaper experimentation via ML).
  • IBM RoboRXN: IBM's autonomous chemistry platform combining NLP-driven synthesis planning with robotic execution. Direct technical overlap with Atinary's Self-Driving Labs, and IBM is already an active collaborator (chemical reaction optimization published 80%+ yield in 23 experiments), making it both a partner and a potential competitor.
  • Chemify: Digital chemistry company building autonomous chemical synthesis platforms using AI-driven code-to-compound workflows. Closely aligned with Atinary's Self-Driving Labs vision in autonomous chemistry execution and serves overlapping pharma/chemicals customers.
  • Emerald Cloud Lab: Remote, fully-automated laboratory platform allowing scientists to run experiments via software interfaces. Competes with Atinary in the lab-automation-as-a-service category, though Emerald focuses on broad wet-lab outsourcing while Atinary emphasizes AI-driven autonomous optimization.
  • Kebotix: AI and robotics platform for materials discovery targeting chemicals, energy, and consumer products. Directly comparable to Atinary's value proposition of combining ML with automated experimentation to accelerate materials R&D.
  • Arctoris: Robotics-as-a-service platform for drug discovery combining automated experimentation with ML-driven analysis. Directly comparable to Atinary's Self-Driving Labs in pharma/biotech R&D automation.

Broad incumbents

  • Schrödinger: Public, multi-product computational chemistry and materials science platform serving pharma and industrial R&D. Overlaps with Atinary on AI-driven molecular and materials optimization, but Schrödinger is a broad platform with physics-based simulation plus ML, while Atinary focuses on closed-loop autonomous experimentation.
  • Valo Health: AI-driven drug discovery platform combining data, computation, and lab automation across the full preclinical pipeline. Overlaps with Atinary in AI for pharma R&D, though Valo is a vertically integrated drug developer rather than a platform vendor.

Emerging players

  • Iktos: AI platform for small molecule drug design focused on generative chemistry and multi-parameter optimization. Comparable in pharmaceutical AI optimization, but Iktos focuses on molecule generation rather than closed-loop lab execution.

Regional players

  • BioMap: AI foundation-model platform for biological R&D with strong presence in Asia. Comparable to Atinary in applying large AI models to scientific discovery, though focused on biologics rather than chemistry/materials and concentrated outside of Atinary's core US/European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Atinary social profiles

Digital presence

Atinary compliance and trust

Trust signal

Compliance4 records

Atinary financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Atinary leadership team

Management profile

Number of profiles

Profiles3 records

Atinary funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Atinary M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atinary

What does Atinary do?

Atinary develops and sells the SDLabs AI Platform, a cloud-based no-code software that combines Bayesian optimization machine learning, transfer-learning algorithms (SeMOpt, Falcon), data analytics, and visualization to solve multi-objective optimization problems in chemistry, materials, and pharmaceutical R&D. The company also delivers Self-Driving Labs, a fully integrated autonomous laboratory system combining AI, robotics (ABB, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise to execute closed-loop Design-Make-Test-Analyze-Learn cycles. Customers access the platform via enterprise annual subscriptions, with deployment in under two hours.

Is Atinary a public or private company?

Atinary is a private company. It is classified as venture growth investor backed and is currently operating.

When was Atinary founded?

Atinary was founded in 2019. It employs 11 to 50 people.

Where is Atinary based?

Atinary is headquartered in Lausanne, Switzerland, in the Europe region.

How does Atinary make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are self-Driving Lab Services.

Who are Atinary's main competitors?

Direct peers on record are Citrine Informatics, IBM RoboRXN, Chemify, Emerald Cloud Lab, Kebotix and Arctoris. Broad incumbents are Schrödinger and Valo Health. Iktos is listed as an emerging player. BioMap is listed as a regional player.

Does Atinary have an API?

Yes. Atinary's platform includes API and SDK access available for integration purposes. The platform offers seamless connectivity with robotic hardware and data systems (LIMS, ELNs, etc.), with an agnostic AI platform to enable Self-Driving Labs mode. The platform deploys in under two hours into existing workflows.

What industry is Atinary in?

Atinary's product category is AI-driven R&D platform for chemistry, materials, and pharmaceutical discovery. Its primary akta.pro industry code is HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management), with a secondary code of HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Mass Spectrometry Web PortalBruker Corporation. (8/11/26). "Press Release: Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories". Boston, MA.Bruker announced an expanded collaboration with Atinary Technologies to integrate Chemspeed automation, Bruker instruments, and SciY software into Atinary's SDLabs agentic AI platform for closed-loop R&D. Bruker made a minority investment in Atinary, with financial details undisclosed. The partnership aims to build on existing Self-Driving Labs in Basel and Boston.Tech.euEuropean tech weekly recap: Over €763M invested across 35+ dealsEuropean tech funding last week totaled over €763 million across more than 35 deals and 10 exits. Software raised the most at €355.3 million, with the UK leading at €393.5 million. Notable rounds included Lovable's $400 million raise and Cambridge Aerospace's $300 million.BioAlpsBruker expands its collaboration with Atinary and makes a minority investmentBruker Corporation expanded its collaboration with Atinary Technologies, acquiring a minority stake in the Lausanne-based company. The deal integrates Chemspeed's laboratory automation, Bruker's analytical instruments, and SciY's software into Atinary's SDLabs platform. Financial terms were not disclosed.startupticker.chBruker makes minority investment in AtinaryBruker Corporation has made a minority investment in Atinary Technologies Inc., expanding their strategic collaboration to integrate AI-driven R&D with analytical technologies. The partnership involves combining Atinary's Self-Driving Labs platform with Bruker's analytical instruments, Chemspeed automation, and SciY software to accelerate scientific discovery in pharmaceuticals and materials.AZoMBruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving LaboratoriesBruker Corporation announced an expanded strategic collaboration with Atinary Technologies to integrate Bruker's analytical instruments and Chemspeed automation platforms into Atinary's AI-driven Self-Driving Labs. As part of this partnership, Bruker made a minority investment in Atinary, though specific financial details were not disclosed. The collaboration aims to accelerate scientific discovery in pharmaceuticals, chemicals, energy, and materials through automated closed-loop R&D workflows.News-MedicalBruker announces strategic collaboration with Atinary Technologies to advance Self-Driving LaboratoriesBruker Corporation announced an expanded strategic collaboration with Atinary Technologies to integrate Bruker's analytical instruments and software into Atinary's Self-Driving Labs platform, accompanied by a minority investment in Atinary. The partnership aims to accelerate scientific discovery in pharmaceuticals, chemicals, and materials by combining automated lab workflows with AI-driven experimentation. While specific financial terms were not disclosed, the collaboration leverages existing joint demonstration laboratories in Switzerland and Boston.BrukerBruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving LaboratoriesBruker announced an expanded strategic collaboration with Atinary Technologies, including a minority investment, to integrate Atinary's SDLabs platform with Chemspeed automation and Bruker instruments. The partnership aims to enable closed-loop agentic AI-driven R&D workflows, with demonstration labs in Basel and Boston.Business Wire BlogBruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving LaboratoriesBruker announced a strategic collaboration and a minority investment in Atinary Technologies to enhance self-driving laboratories with AI-driven R&D capabilities. The partnership aims to integrate Bruker instruments with Atinary's SDLabs platform for autonomous chemical research and discovery.Chemical & Engineering NewsSelf-driving labs are changing how chemists workAtinary Technologies opened an AI-powered self-driving chemistry laboratory in Boston's Seaport neighborhood in early February, having raised at least $10 million to expand its R&D platform for molecular and materials discovery. Radical AI launched a similar autonomous facility at the Alexandria Center for Life Science in New York City, having raised $65 million to develop advanced alloys for extreme environments such as hypersonic vehicles and spacecraft. Both labs use AI agents that design experiments after scanning scientific literature, with robots executing protocols and feeding data back to the agents in iterative learning loops—a process that can accomplish in days what would take human chemists weeks.startupticker.chTwo Swiss startups recognized as WEF’s Technology PioneersThe World Economic Forum announced its 2026 Technology Pioneers cohort of 100 early-stage companies from 23 countries, with Swiss startups Atinary and Metafuels among the honorees for their work in AI-driven R&D and sustainable aviation fuel respectively. Atinary, which has launched a Self-Driving Lab in Boston, and Metafuels, which is developing its aerobrew methanol-to-jet technology at facilities in Switzerland and Rotterdam, will join the Forum's global platform to engage with leaders across industries and governments. The recognition comes as deep tech investment surges and AI accounts for over 60% of global venture capital.